Whilst profound results in multiple illnesses i think it’s fair to say nothing is set in stone or yet to see results in human trials means no revenue and just bells and whistles. But as a investor my concerns are Invion spreading into multiple nations for R&D frankly I think it’s unnecessary, who will fund these projects and where will the funds come from?
Existing investors concerns maybe like mine, our shares been diluted by CR funding international R&D and we don’t need that. Perhaps Invion has over extended them selves imo time is running out human trail results are needed.
not professional DYOR
Ann: Photosoft Effective Against Superbugs and Other Pathogens, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 12.5¢ | $74.92K | 574.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54000 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 61 | 1 |
View Market Depth
| Last trade - 13.01pm 16/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |